References

1. The Choroidal Neovascularization Prevention Trial Research Group. Choroidal neovascularization in the Choroidal Neovascularization Prevention trial. Ophthalmology. 1998;105(8):1364-72. PubMed | Google Scholar


2. Weingessel B, Hintermayer G, Maca SM, Rauch R, Vecsei-Marlovits PV. The signifi cance of early treatment of exudative age-related macular degeneration: 12 months? results. Wien Klin Wochenschr. 2012 Nov;124(21-22):750-5. PubMed | Google Scholar


3. Reardon W, Ross RJ, Sweeney MG et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 1992;340(8832):1376-9. PubMed | Google Scholar


4. Massin P, Dubois-Laforgue D, Meas T et al. GEDIAM (Mitochondrial Diabetes French Study Group): retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness): a case-control study. Diabetologia. 2008;51(9):1664-70. Google Scholar